Financials data is unavailable for this security.
View more
Year on year Observe Medical ASA had net income fall 18.82% from a loss of 50.80m to a larger loss of 60.36m despite revenues that grew 43.14% from 19.52m to 27.94m over the same period.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in NOKView more
In 2023, Observe Medical ASA did not generate a significant amount of cash. Cash Flow from Financing totalled 31.74m or 113.59% of revenues. In addition the company used 24.46m for operations while cash used for investing totalled 7.63m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.5635 |
---|---|
Tangible book value per share | -0.579 |
More ▼
Balance sheet in NOKView more
Current ratio | 0.2527 |
---|---|
Quick ratio | 0.193 |
Total debt/total equity | 0.5209 |
---|---|
Total debt/total capital | 0.3425 |
More ▼